Current filters:
Start a new search
Add filters:

Use filters to refine the search results.

Results 11-20 of 47 (Search time: 0.007 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2006Suspected DLIS interference in the dimension DGNA digoxin assay method and the clinical application of the revised digoxin target rangeMorris, R.; Jones, T.; Goldsworthy, S.; Wagner, T.; Ho, H.; Horowitz, J.
2005Relationships between sirolimus dosing, concentration and outcomes in renal transplant recipientsDansirikul, C.; Duffull, S.; Morris, R.; Tett, S.
2005Immunosuppressant drug monitoring: Is the laboratory meeting clinical expectations?Morris, R.
2006CEDIA (R) mycophenolic acid assay compared with HPLC-UV in specimens from transplant recipientsWestley, I.; Ray, J.; Morris, R.
2004Analytic aspects of cyclosporine monitoring, on behalf of the IFCC/IATDMCT joint working groupMorris, R.; Holt, D.; Armstrong, V.; Griesmacher, A.; Napoli, K.; Shaw, L.
2002International federation of clinical chemistry/international association of therapeutic drug monitoring and clinical toxicology working group on immunosuppressive drug monitoringHolt, D.; Armstrong, V.; Griesmacher, A.; Morris, R.; Napoli, K.; Shaw, L.
2000Cyclosporin assays, metabolite cross-reactivity, and pharmacokinetic monitoringMorris, R.
2003Immunosupressant drug monitoring - recent innovations with emphasis on cyclosporineMorris, R.; Holt, D.; Shaw, L.
2004Clinical inhibition of CYP2D6-catalysed metabolism by the antianginal agent perhexilineDavies, B.; Coller, J.; James, H.; Gillis, D.; Somogyi, A.; Horowitz, J.; Morris, R.; Sallustio, B.
2000Clinical study of lamotrigine and valproic acid in patients with epilepsy: Using a drug interaction to advantage?Morris, R.; Black, A.; Lam, E.; Westley, I.